β³ Fetching live dividend data...
Home βΊ Calculator βΊ PVTTF Dividend Calculator 2026
Pivotal Therapeutics Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in PVTTF β $2.8938885275744073e+28M in 10 years Β· $2,409,405,308,201,291,200,000,000,000,000,000.00/month
Pivotal Therapeutics Inc. is a specialized pharmaceutical firm primarily dedicated to addressing cardiovascular ailments and promoting general well-being. The company's flagship offering, VASCAZEN, is a medical food available by prescription only. It's specifically designed for the clinical dietary intervention of cardiovascular disease in individuals diagnosed with coronary heart disease who also exhibit low levels of Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in their bloodstream. Furthermore, Pivotal Therapeutics markets OMAZEN, which aims to support general health by boosting Omega-3 fatty acid concentrations. Its Benefishial product line is under development, targeting a wide range of health needs such as comprehensive well-being, heart health, maternal and fetal health, and specific formulations for toddlers, children, and even pets. A significant pipeline asset, PVT-100, is being developed to stabilize fragile plaque formations in patients undergoing carotid endarterectomy. Currently, VASCAZEN is distributed within the United States, while OMAZEN is sold in Canada. The corporate headquarters for Pivotal Therapeutics Inc. are situated in Woodbridge, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open PVTTF position with:
Real after-tax yield depends on where you live and how you hold PVTTF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| πΊπΈ US Taxable (20%) | 20% | 88888.89% | 88886.09% | $8,888,889 / yr |
| π¬π§ UK ISA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| π¬π§ UK Taxable | 8.75% | 101388.89% | 101386.09% | $10,138,889 / yr |
| π¨π¦ TFSA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| π¨π¦ CA Taxable | 25% | 83333.33% | 83330.53% | $8,333,333 / yr |
| π¦πΊ Super (pension) | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| π¦πΊ AU Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
| π©πͺ DE Taxable | 26.375% | 81805.55% | 81802.75% | $8,180,555 / yr |
| π«π· FR Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
PVTTF pays quarterly β 4 times per year. Next ex-div: TBD.
How PVTTF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PVTTF sourced from FMP /financial-growth endpoint β real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PVTTF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Pivotal Therapeutics Inc. (PVTTF) is currently trading at $0.00, 97% below its 52-week high. The current dividend yield is 111111.11% based on an annual payout of $2.00 per share.
Pivotal Therapeutics Inc. (PVTTF) is a healthcare stock currently trading at $0.00 with a dividend yield of 111111.11%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β